Research grade vs GMP grade peptides: what the label difference means

Two labels that are not the same kind of claim

"GMP" points to an external system with published requirements and regulators who inspect against them. "Research grade" is a commercial description. We found no FDA or ICH definition of the term, so its meaning comes entirely from what a supplier states and documents for a given lot.

This page explains the documentation difference for laboratory buyers. It does not suggest that either grade is suitable for any human or animal use.

What CGMP means in FDA's words

FDA describes CGMP as the Current Good Manufacturing Practice regulations it enforces, requiring manufacturers to establish strong quality management systems, obtain appropriate quality raw materials, maintain operating procedures, detect and investigate product quality deviations and maintain reliable testing laboratories. FDA states that the regulations contain minimum requirements and that the "C" means systems must be kept current. [1]

FDA lists 21 CFR Parts 210 and 211, and Part 212 for PET drugs, as its drug CGMP regulations, which set minimum requirements for the methods, facilities and controls used in manufacturing. [2] FDA also notes that a drug made in violation of CGMP is considered adulterated even though that does not necessarily mean something is wrong with the drug. [1] GMP is about the manufacturing system, not proof of quality for one vial.

What ICH Q7 adds for active ingredients

ICH Q7, published by FDA as guidance, applies GMP to the manufacture of active pharmaceutical ingredients for human drug products, including those made by chemical synthesis. [3] [4] It recommends a quality unit independent of production that covers quality assurance and quality control, named persons authorized to release material, quality activities recorded when performed, and quarantine pending approval or rejection. [4]

Q7 also sets out what a certificate of analysis should contain: name and grade, batch number, release date, expiry or retest date, each test with acceptance limits and numerical results, a signature and date from authorized quality personnel, and the name, address and telephone number of the original manufacturer. [4] Its chapters cover validation, change control, complaints and recalls, and contract laboratories. [4] Section 19 gives separate, stage-appropriate guidance for APIs made for clinical trials, still requiring an independent quality unit to approve or reject each batch. [4]

Side by side

The table shows what a GMP claim should be able to support with documents, and what a research-grade listing may or may not provide.

Questions to ask about a "GMP" claim

A supplier that describes a peptide as GMP grade should be able to answer specific questions. Which GMP standard: 21 CFR 211, ICH Q7 or another? Which manufacturing site, and which regulator, if any, has inspected it? Is this lot released by an independent quality unit, and does the certificate carry that signature and the original manufacturer's name and address? Is there a change-control record if the process changed between lots? A general phrase like "made in a GMP facility" without lot-level evidence answers none of these.

Record the answers verbatim with the date. If the answer is that the facility follows GMP but the lot was sold as research grade, record both statements; the lot-level documents are what you have.

A fictional pair of listings

Invented listing A says "GMP grade, 98%." Invented listing B says "research grade, 98%." Listing A's certificate is unsigned and names no manufacturer; listing B's is signed by a named quality manager, names the manufacturing site and gives a retest date. On the documents you hold, B is better documented than A, despite the label. The record should note: "A: GMP claimed, no lot-level GMP evidence; requested quality-unit release and manufacturer identity. B: research grade; certificate meets most Q7 11.4 elements."